RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients
2014 Guadagnuolo, Viviana; Papayannidis, Cristina; Iacobucci, Ilaria; Padella, Antonella; Simonetti, Giorgia; Paolini, Stefania; Abbenante, Mariachiara; Parisi, Sarah; Volpato, Francesca; Sartor, Chiara; Fontana, MARIA CHIARA; Ottaviani, Emanuela; Ferrari, Anna; Testoni, Nicoletta; Baldazzi, Carmen; Delledonne, Massimo; Fili', Carla; Malagola, Michele; Cattina, Federica; Bernardi, Simona; Russo, Domenico; Martinelli, Giovanni
SNP array reveals a new deletion of JAK2 in AML patients
2015 Viviana Guadagnuolo, Maria Chiara Fontana, Antonella Padella, Ilaria Iacobucci, Cristina Papayannidis, Giorgia Simonetti, Anna Ferrari, Giovanni Marconi, Stefania Paolini, Maria Chiara Abbenante, Sarah Parisi, Francesca Volpato, Chiara Sartor, Emanuela Ottaviani, Massimo Delledonne, Michele Cavo, Guido Biasco, Giovanni Martinelli
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up
2017 Giovanni Marconi, Cristina Papayannidis, Maria Chiara Fontana, Antonella Padella, Anna Ferrari, Eugenia Franchini, Stefania Paolini, Maria Chiara Abbenante, Chiara Sartor, Francesca Volpato, Viviana Guadagnuolo, Silvia Lo Monaco, Elena Tenti, Andrea Ghelli Luserna Di Rora, Valentina Robustelli, Nicoletta Testoni, Giorgia Simonetti, Emanuela Ottaviani, Giovanni Martinelli
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia
2015 Andrea Ghelli Luserna Di Rora, Ilaria Iacobucci, Enrica Imbrogno, Enrico Derenzini, Anna Ferrari, Viviana Guadagnuolo, Valentina Robustelli, Simona Soverini, Cristina Papayannidis, Maria Chiara Abbenante, Michele Cavo, Giovanni Martinelli
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2011 Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Brighenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli
The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia
2016 Andrea Ghelli Luserna di Rora, Ilaria Iacobucci, Enrica Imbrogno, Enrico Derenzini, Anna Ferrari, Valentina Robustelli, Viviana Guadagnuolo, Cristina Papayannidis, Maria Chiara Abbenante, Sandro Grilli, Giovanni Martinelli
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia
2011 Ilaria Iacobucci, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, Giovanni Martinelli
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome
2014 Anna Ferrari, Ilaria Iacobucci, Cristina Papayannidis, Carmen Baldazzi, Chiara Sartor, Emanuela Ottaviani, Nicoletta Testoni, Valentina Robustelli, Margherita Perricone, Claudia Venturi, Maria Chiara Abbenante, Viviana Guadagnuolo, Antonella Padella, Federica Cattina, Giorgia Simonetti, Domenico Russo, Giovanni Martinelli
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome
2015 Ferrari, Anna; Papayannidis, Cristina; Zuffa, Elisa; Baldazzi, Carmen; Padella, Antonella; Franchini, Eugenia; Iacobucci, Ilaria; Paolini, Stefania; Guadagnuolo, Viviana; Perricone, Margherita; Robustelli, Valentina; Venturi, Claudia; Abbenante, Mariachiara; Parisi, Sarah; Sartor, Chiara; Volpato, Francesca; Cattina, Federica; Simonetti, Giorgia; Fontana, MARIA CHIARA; Bochicchio, MARIA TERESA; Frabetti, Federica; Lani, Elisa; Mancuso, Katia; Zannetti, BEATRICE ANNA; Luatti, Simona; Ottaviani, Emanuela; Testoni, Nicoletta; Martinelli, Giovanni
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse.
2012 Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients | Guadagnuolo, Viviana; Papayannidis, Cristina; Iacobucci, Ilaria; Padella, Antonella; Simonetti, G...iorgia; Paolini, Stefania; Abbenante, Mariachiara; Parisi, Sarah; Volpato, Francesca; Sartor, Chiara; Fontana, MARIA CHIARA; Ottaviani, Emanuela; Ferrari, Anna; Testoni, Nicoletta; Baldazzi, Carmen; Delledonne, Massimo; Fili', Carla; Malagola, Michele; Cattina, Federica; Bernardi, Simona; Russo, Domenico; Martinelli, Giovanni | 2014-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
SNP array reveals a new deletion of JAK2 in AML patients | Viviana Guadagnuolo, Maria Chiara Fontana, Antonella Padella, Ilaria Iacobucci, Cristina Papayann...idis, Giorgia Simonetti, Anna Ferrari, Giovanni Marconi, Stefania Paolini, Maria Chiara Abbenante, Sarah Parisi, Francesca Volpato, Chiara Sartor, Emanuela Ottaviani, Massimo Delledonne, Michele Cavo, Guido Biasco, Giovanni Martinelli | 2015-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up | Giovanni Marconi, Cristina Papayannidis, Maria Chiara Fontana, Antonella Padella, Anna Ferrari, E...ugenia Franchini, Stefania Paolini, Maria Chiara Abbenante, Chiara Sartor, Francesca Volpato, Viviana Guadagnuolo, Silvia Lo Monaco, Elena Tenti, Andrea Ghelli Luserna Di Rora, Valentina Robustelli, Nicoletta Testoni, Giorgia Simonetti, Emanuela Ottaviani, Giovanni Martinelli | 2017-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia | Andrea Ghelli Luserna Di Rora, Ilaria Iacobucci, Enrica Imbrogno, Enrico Derenzini, Anna Ferrari,... Viviana Guadagnuolo, Valentina Robustelli, Simona Soverini, Cristina Papayannidis, Maria Chiara Abbenante, Michele Cavo, Giovanni Martinelli | 2015-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Bri...ghenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia | Andrea Ghelli Luserna di Rora, Ilaria Iacobucci, Enrica Imbrogno, Enrico Derenzini, Anna Ferrari,... Valentina Robustelli, Viviana Guadagnuolo, Cristina Papayannidis, Maria Chiara Abbenante, Sandro Grilli, Giovanni Martinelli | 2016-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia | Ilaria Iacobucci, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto ...Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome | Anna Ferrari, Ilaria Iacobucci, Cristina Papayannidis, Carmen Baldazzi, Chiara Sartor, Emanuela O...ttaviani, Nicoletta Testoni, Valentina Robustelli, Margherita Perricone, Claudia Venturi, Maria Chiara Abbenante, Viviana Guadagnuolo, Antonella Padella, Federica Cattina, Giorgia Simonetti, Domenico Russo, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome | Ferrari, Anna; Papayannidis, Cristina; Zuffa, Elisa; Baldazzi, Carmen; Padella, Antonella; Franch...ini, Eugenia; Iacobucci, Ilaria; Paolini, Stefania; Guadagnuolo, Viviana; Perricone, Margherita; Robustelli, Valentina; Venturi, Claudia; Abbenante, Mariachiara; Parisi, Sarah; Sartor, Chiara; Volpato, Francesca; Cattina, Federica; Simonetti, Giorgia; Fontana, MARIA CHIARA; Bochicchio, MARIA TERESA; Frabetti, Federica; Lani, Elisa; Mancuso, Katia; Zannetti, BEATRICE ANNA; Luatti, Simona; Ottaviani, Emanuela; Testoni, Nicoletta; Martinelli, Giovanni | 2015-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. | Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, An...gelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 - Contributo in rivista 55
- 1 - Contributo in rivista::1.06 A... 55
Data di pubblicazione
- 2017 10
- 2016 12
- 2015 11
- 2014 13
- 2013 1
- 2012 3
- 2011 3
- 2010 1
- 2009 1
Rivista
- BLOOD 30
- CANCER RESEARCH 21
- JOURNAL OF CLINICAL ONCOLOGY 3
- CLINICAL CANCER RESEARCH 1
Keyword
- Acute Lymphoblastic Leukemia 16
- Acute Myeloid Leukemia 15
- TP53 5
- AML 3
- Aneuploidy 3
- Checkpoint 3
- acute myeloid leukemia 2
- BCR-ABL1 2
- copy number alterations 2
- Mastocytosis 2
Lingua
- eng 55
Accesso al fulltext
- no fulltext 55